The National Biotechnology Initiative Act is a bill introduced during the 119th Congress in the U.S. Senate and the U.S. House of Representatives. The bill is one of the major recommendations put forth by the National Security Commission on Emerging Biotechnology. [1]
The National Biotechnology Initiative Act (NBIA) aims to improve federal coordination on emerging biotechnology and streamline outdated and ineffective regulatory structures that inhibit biotechnology innovation. [2]
Specifically, according to lawmakers, the legislation promotes federal coordination on biotechnology by establishing:
In April 2025, the Congressional Commissioners of the National Security Commission on Emerging Biotechnology introduced the NBIA in both the House and the Senate. Senators Todd Young and Alex Padilla introduced S.1387 and Representatives Stephanie Bice and Ro Khanna introduced H.R.2756. [4] [5]
The bill has been endorsed by several biotechnology trade associations, companies, and industry leaders, including: